Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126398441 | 12639844 | 1 | I | 20160729 | 20160810 | 20160810 | EXP | GB-MHRA-MIDB-E6551D68-C508-46D5-A29B-DB3EC626DECD | GB-TEVA-682636ACC | TEVA | 15.00 | YR | Y | 0.00000 | 20160810 | PH | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126398441 | 12639844 | 1 | PS | TRIMETHOPRIM. | TRIMETHOPRIM | 1 | Oral | 400 MILLIGRAM DAILY; | Y | Y | 18679 | 200 | MG | TABLET | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126398441 | 12639844 | 1 | Acne |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126398441 | 12639844 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126398441 | 12639844 | Contusion | Contusion |
126398441 | 12639844 | Rash | Rash |
126398441 | 12639844 | Rash morbilliform | Rash morbilliform |
126398441 | 12639844 | Skin exfoliation | Skin exfoliation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126398441 | 12639844 | 1 | 201601 | 0 |